IQVIA Holdings Basic EPS 2011-2025 | IQV
IQVIA Holdings annual/quarterly basic eps history and growth rate from 2011 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
- IQVIA Holdings basic eps for the quarter ending June 30, 2025 was $1.55, a 22.11% decline year-over-year.
- IQVIA Holdings basic eps for the twelve months ending June 30, 2025 was $6.97, a 10.53% decline year-over-year.
- IQVIA Holdings annual basic eps for 2024 was $0.008B, a 2.44% increase from 2023.
- IQVIA Holdings annual basic eps for 2023 was $0.007B, a 26.98% increase from 2022.
- IQVIA Holdings annual basic eps for 2022 was $0.006B, a 15.25% increase from 2021.
| IQVIA Holdings Annual Basic EPS | |
|---|---|
| 2024 | $7.57 |
| 2023 | $7.39 |
| 2022 | $5.82 |
| 2021 | $5.05 |
| 2020 | $1.46 |
| 2019 | $0.98 |
| 2018 | $1.27 |
| 2017 | $5.86 |
| 2016 | $0.48 |
| 2015 | $3.15 |
| 2014 | $2.78 |
| 2013 | $1.83 |
| 2012 | $1.53 |
| 2011 | $2.08 |
| 2010 | $1.38 |
| IQVIA Holdings Quarterly Basic EPS | |
|---|---|
| 2025-06-30 | $1.55 |
| 2025-03-31 | $1.42 |
| 2024-12-31 | $2.43 |
| 2024-09-30 | $1.57 |
| 2024-06-30 | $1.99 |
| 2024-03-31 | $1.58 |
| 2023-12-31 | $2.56 |
| 2023-09-30 | $1.66 |
| 2023-06-30 | $1.61 |
| 2023-03-31 | $1.56 |
| 2022-12-31 | $1.23 |
| 2022-09-30 | $1.52 |
| 2022-06-30 | $1.36 |
| 2022-03-31 | $1.71 |
| 2021-12-31 | $1.67 |
| 2021-09-30 | $1.36 |
| 2021-06-30 | $0.91 |
| 2021-03-31 | $1.11 |
| 2020-12-31 | $0.62 |
| 2020-09-30 | $0.53 |
| 2020-06-30 | $-0.12 |
| 2020-03-31 | $0.43 |
| 2019-12-31 | $0.09 |
| 2019-09-30 | $0.29 |
| 2019-06-30 | $0.31 |
| 2019-03-31 | $0.29 |
| 2018-12-31 | $0.34 |
| 2018-09-30 | $0.30 |
| 2018-06-30 | $0.30 |
| 2018-03-31 | $0.33 |
| 2017-12-31 | $4.74 |
| 2017-09-30 | $0.41 |
| 2017-06-30 | $0.28 |
| 2017-03-31 | $0.43 |
| 2016-12-31 | $-1.97 |
| 2016-09-30 | $0.83 |
| 2016-06-30 | $0.73 |
| 2016-03-31 | $0.89 |
| 2015-12-31 | $0.86 |
| 2015-09-30 | $0.91 |
| 2015-06-30 | $0.69 |
| 2015-03-31 | $0.69 |
| 2014-12-31 | $0.70 |
| 2014-09-30 | $0.73 |
| 2014-06-30 | $0.66 |
| 2014-03-31 | $0.69 |
| 2013-12-31 | $0.58 |
| 2013-09-30 | $0.52 |
| 2013-06-30 | $0.31 |
| 2013-03-31 | $0.42 |
| 2012-12-31 | $0.30 |
| 2012-09-30 | $0.45 |
| 2012-06-30 | $0.41 |
| 2012-03-31 | $0.37 |
| 2011-12-31 | |
| 2010-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $32.438B | $15.405B |
| IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in updated and innovative ideas in the process of clinical development and commercialization, speed innovation and accelerate improvements. I | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $186.057B | 22.51 |
| Intuitive Surgical (ISRG) | United States | $169.665B | 70.33 |
| IDEXX Laboratories (IDXX) | United States | $51.770B | 53.88 |
| Edwards Lifesciences (EW) | United States | $47.755B | 31.65 |
| Alcon (ALC) | Switzerland | $39.366B | 26.43 |
| DexCom (DXCM) | United States | $29.545B | 44.32 |
| Mettler-Toledo (MTD) | United States | $26.800B | 31.81 |
| STERIS (STE) | Ireland | $24.136B | 25.69 |
| Waters (WAT) | United States | $17.964B | 24.68 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.399B | 0.00 |
| Hologic (HOLX) | United States | $14.929B | 16.17 |
| Penumbra (PEN) | United States | $10.633B | 77.68 |
| Globus Medical (GMED) | United States | $8.275B | 19.09 |
| Sysmex ADR (SSMXY) | Japan | $7.913B | 25.14 |
| Masimo (MASI) | United States | $7.590B | 25.54 |
| Teleflex (TFX) | United States | $5.586B | 9.02 |
| Glaukos (GKOS) | United States | $5.495B | 0.00 |
| TransMedics (TMDX) | United States | $3.919B | 59.56 |
| Integer Holdings (ITGR) | United States | $3.779B | 18.86 |
| LivaNova (LIVN) | United Kingdom | $3.078B | 17.62 |
| Veracyte (VCYT) | United States | $2.387B | 32.98 |
| Alphatec Holdings (ATEC) | United States | $2.353B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.235B | 0.00 |
| Artivion (AORT) | United States | $2.073B | 104.60 |
| Nihon Kohden (NHNKY) | Japan | $1.992B | 23.78 |
| Elekta AB (EKTAY) | Sweden | $1.815B | 17.59 |
| Integra LifeSciences Holdings (IART) | United States | $1.179B | 6.75 |
| OPKO Health (OPK) | United States | $1.095B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.046B | 0.00 |
| IRadimed (IRMD) | United States | $0.921B | 44.72 |
| Tandem Diabetes Care (TNDM) | United States | $0.845B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.819B | 0.00 |
| AxoGen (AXGN) | United States | $0.743B | 0.00 |
| SiBone (SIBN) | United States | $0.719B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.592B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.554B | 9.79 |
| OrthoPediatrics (KIDS) | United States | $0.536B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.464B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.439B | 3.52 |
| AngioDynamics (ANGO) | United States | $0.417B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.393B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.385B | 91.83 |
| Mesa Laboratories (MLAB) | United States | $0.373B | 9.48 |
| RxSight (RXST) | United States | $0.370B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.309B | 0.00 |
| NeuroPace (NPCE) | United States | $0.303B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.298B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.297B | 20.48 |
| Alpha Tau Medical (DRTS) | Israel | $0.290B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.236B | 0.00 |
| 908 Devices (MASS) | United States | $0.224B | 0.00 |
| Neuronetics (STIM) | United States | $0.220B | 0.00 |
| Inogen (INGN) | United States | $0.216B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.213B | 0.00 |
| CVRx (CVRX) | United States | $0.205B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.174B | 0.00 |
| Accuray (ARAY) | United States | $0.171B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.150B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.137B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.107B | 0.00 |
| InspireMD (NSPR) | United States | $0.102B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.099B | 0.00 |
| Hyperfine (HYPR) | United States | $0.097B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.088B | 0.00 | |
| EDAP TMS S.A (EDAP) | France | $0.085B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.015B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.60 |